These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38833634)
1. A Microfluidic Chip-Based Automated System for Whole-Course Monitoring the Drug Responses of Organoids. Zhang K; Xi J; Wang Y; Xue J; Li B; Huang Z; Zheng Z; Liang N; Wei Z Anal Chem; 2024 Jun; 96(24):10092-10101. PubMed ID: 38833634 [TBL] [Abstract][Full Text] [Related]
2. A dual-functional microfluidic chip for guiding personalized lung cancer medicine: combining EGFR mutation detection and organoid-based drug response test. Zhang K; Xi J; Zhao H; Wang Y; Xue J; Liang N; Wei Z Lab Chip; 2024 Mar; 24(6):1762-1774. PubMed ID: 38352981 [TBL] [Abstract][Full Text] [Related]
3. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity. Jung DJ; Shin TH; Kim M; Sung CO; Jang SJ; Jeong GS Lab Chip; 2019 Sep; 19(17):2854-2865. PubMed ID: 31367720 [TBL] [Abstract][Full Text] [Related]
4. Real-time monitoring ATP variation in human cancer organoids for a long term by DNA-based nanosensor. Zhang K; Wang Y; Xue J; Liang N; Wei Z Anal Chim Acta; 2023 Sep; 1275():341608. PubMed ID: 37524457 [TBL] [Abstract][Full Text] [Related]
5. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform. Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138 [TBL] [Abstract][Full Text] [Related]
6. Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids. Schuster B; Junkin M; Kashaf SS; Romero-Calvo I; Kirby K; Matthews J; Weber CR; Rzhetsky A; White KP; Tay S Nat Commun; 2020 Oct; 11(1):5271. PubMed ID: 33077832 [TBL] [Abstract][Full Text] [Related]
7. A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation. Zhang C; Tian K; Meng Z; Zhang J; Lu Y; Tan L; Zhang M; Xu D Talanta; 2024 Sep; 277():126298. PubMed ID: 38823330 [TBL] [Abstract][Full Text] [Related]
8. Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening. Fang G; Lu H; Rodriguez de la Fuente L; Law AMK; Lin G; Jin D; Gallego-Ortega D Adv Sci (Weinh); 2021 Nov; 8(21):e2102418. PubMed ID: 34494727 [TBL] [Abstract][Full Text] [Related]
9. Quantitatively Evaluating Interactions between Patient-Derived Organoids and Autologous Immune Cells by Microfluidic Chip. Gao M; Ding W; Wang Y; Li B; Huang Z; Liang N; Wei Z Anal Chem; 2024 Aug; 96(32):13061-13069. PubMed ID: 39093612 [TBL] [Abstract][Full Text] [Related]
10. Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Hu Y; Sui X; Song F; Li Y; Li K; Chen Z; Yang F; Chen X; Zhang Y; Wang X; Liu Q; Li C; Zou B; Chen X; Wang J; Liu P Nat Commun; 2021 May; 12(1):2581. PubMed ID: 33972544 [TBL] [Abstract][Full Text] [Related]
11. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM Elife; 2020 Nov; 9():. PubMed ID: 33138918 [TBL] [Abstract][Full Text] [Related]
12. Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations. Jabs J; Zickgraf FM; Park J; Wagner S; Jiang X; Jechow K; Kleinheinz K; Toprak UH; Schneider MA; Meister M; Spaich S; Sütterlin M; Schlesner M; Trumpp A; Sprick M; Eils R; Conrad C Mol Syst Biol; 2017 Nov; 13(11):955. PubMed ID: 29180611 [TBL] [Abstract][Full Text] [Related]
13. Patient-Derived Organoids as a Model for Cancer Drug Discovery. Rae C; Amato F; Braconi C Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801782 [TBL] [Abstract][Full Text] [Related]
14. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study. Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038 [TBL] [Abstract][Full Text] [Related]
15. Forming Single-Cell-Derived Colon Cancer Organoid Arrays on a Microfluidic Chip for High Throughput Tumor Heterogeneity Analysis. Chen Z; Chen J; Lin D; Kang H; Luo Y; Wang X; Wang L; Liu D ACS Biomater Sci Eng; 2024 Aug; 10(8):5265-5273. PubMed ID: 39087916 [TBL] [Abstract][Full Text] [Related]
16. Microfluidic organ-on-chip system for multi-analyte monitoring of metabolites in 3D cell cultures. Dornhof J; Kieninger J; Muralidharan H; Maurer J; Urban GA; Weltin A Lab Chip; 2022 Jan; 22(2):225-239. PubMed ID: 34851349 [TBL] [Abstract][Full Text] [Related]
17. Drug testing of monodisperse arrays of live microdissected tumors using a valved multiwell microfluidic platform. Lockhart EJ; Horowitz LF; Rodríguez A; Zhu S; Nguyen T; Mehrabi M; Gujral TS; Folch A Lab Chip; 2024 May; 24(10):2683-2699. PubMed ID: 38651213 [TBL] [Abstract][Full Text] [Related]
18. From Organ-on-a-Chip to Human-on-a-Chip: A Review of Research Progress and Latest Applications. Huang Y; Liu T; Huang Q; Wang Y ACS Sens; 2024 Jul; 9(7):3466-3488. PubMed ID: 38991227 [TBL] [Abstract][Full Text] [Related]
19. Establishment of advanced tumor organoids with emerging innovative technologies. Mao Y; Hu H Cancer Lett; 2024 Aug; 598():217122. PubMed ID: 39029781 [TBL] [Abstract][Full Text] [Related]
20. Pancreatic islet organoids-on-a-chip: how far have we gone? Yin J; Meng H; Lin J; Ji W; Xu T; Liu H J Nanobiotechnology; 2022 Jun; 20(1):308. PubMed ID: 35764957 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]